284 related articles for article (PubMed ID: 38571964)
21. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
[TBL] [Abstract][Full Text] [Related]
22. Direct and Indirect Effect of TGFβ on Treg Transendothelial Recruitment in HCC Tissue Microenvironment.
Dituri F; Mancarella S; Serino G; Chaoul N; Lupo LG; Villa E; Fabregat I; Giannelli G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769191
[TBL] [Abstract][Full Text] [Related]
23. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma.
Shen X; Li N; Li H; Zhang T; Wang F; Li Q
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1745-54. PubMed ID: 20221638
[TBL] [Abstract][Full Text] [Related]
24. Expression of CD4+CD25+CD127
Zhou W; Deng J; Chen Q; Li R; Xu X; Guan Y; Li W; Xiong X; Li H; Li J; Cai X
Int J Med Sci; 2020; 17(6):712-719. PubMed ID: 32218692
[No Abstract] [Full Text] [Related]
25. Providence of the CD25
Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells.
Cao M; Cabrera R; Xu Y; Firpi R; Zhu H; Liu C; Nelson DR
Lab Invest; 2007 Jun; 87(6):582-90. PubMed ID: 17372588
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol exerts antitumor effects by downregulating CD8
Zhang Q; Huang H; Zheng F; Liu H; Qiu F; Chen Y; Liang CL; Dai Z
Oncoimmunology; 2020 Oct; 9(1):1829346. PubMed ID: 33150044
[TBL] [Abstract][Full Text] [Related]
28. Fine-tuning of regulatory T cells is indispensable for the metabolic steatosis-related hepatocellular carcinoma: A review.
Riaz F; Wei P; Pan F
Front Cell Dev Biol; 2022; 10():949603. PubMed ID: 35912096
[TBL] [Abstract][Full Text] [Related]
29. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.
Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z
J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990
[TBL] [Abstract][Full Text] [Related]
30. IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment.
Zhang S; Gan X; Qiu J; Ju Z; Gao J; Zhou J; Shi C; Zhu Y; Li Z
Mol Immunol; 2021 May; 133():163-172. PubMed ID: 33667986
[TBL] [Abstract][Full Text] [Related]
31. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
[TBL] [Abstract][Full Text] [Related]
32. Regulatory T-Cell Therapy in Liver Transplantation and Chronic Liver Disease.
Hann A; Oo YH; Perera MTPR
Front Immunol; 2021; 12():719954. PubMed ID: 34721383
[TBL] [Abstract][Full Text] [Related]
33. [The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients].
Zhang HH; Fei R; Mei MH; Liao WJ; Wang XY; Cong X; Qin LL; Ji Y; Wang SX; Wei L; Chen HS
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):266-72. PubMed ID: 17456313
[TBL] [Abstract][Full Text] [Related]
34. Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets.
Yang XF
Front Biosci; 2008 Jan; 13():1472-99. PubMed ID: 17981643
[TBL] [Abstract][Full Text] [Related]
35. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients.
Zhou J; Ding T; Pan W; Zhu LY; Li L; Zheng L
Int J Cancer; 2009 Oct; 125(7):1640-8. PubMed ID: 19569243
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling.
Yang J; Zhang JX; Wang H; Wang GL; Hu QG; Zheng QC
World J Gastroenterol; 2012 Jun; 18(23):2938-47. PubMed ID: 22736917
[TBL] [Abstract][Full Text] [Related]
37. ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology Analysis.
Lu LC; Deantonio C; Palu CC; Lee YH; Mitchell LS; Cowan M; Corser M; Sherry L; Cheng AL; Quaratino S; Shao YY; Sainson RCA; Hsu CH
Oncology; 2022; 100(8):419-428. PubMed ID: 35709702
[TBL] [Abstract][Full Text] [Related]
38. The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma.
He J; Miao R; Chen Y; Wang H; Liu M
Immunology; 2024 Apr; 171(4):445-463. PubMed ID: 38093705
[TBL] [Abstract][Full Text] [Related]
39. FoxP3
Saleh R; Elkord E
Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
[TBL] [Abstract][Full Text] [Related]
40. Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity.
Chen ML; Yan BS; Lu WC; Chen MH; Yu SL; Yang PC; Cheng AL
Int J Cancer; 2014 Jan; 134(2):319-31. PubMed ID: 23818246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
